Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ALDXALDX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ALDEYRA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 725,444 shares of ALDX (ALDEYRA THERAPEUTICS INC), worth $1.5M as of 2026-Q2. The position was increased (+33.6% shares). ALDX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$1.5M

Current Shares

725,444

Total Value Change

+$345,929

Total Shares Change

+485,110

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
725,444
+33.6%
$1.5M0.0%$2.13
33
2026-Q1
Increased
543,146
+77.7%
$917,9170.0%$5.11
38
2025-Q4
Increased
305,706
+67.1%
$1.6M0.0%$5.15
38
2025-Q3
Increased
182,943
+31.0%
$954,9620.0%$5.21
32
2025-Q2
Increased
139,614
+12.3%
$534,7210.0%$3.79
27
2025-Q1
Decreased
124,365
-48.3%
$715,0990.0%$6.67
0
2024-Q4
New
240,334
-
$1.2M0.0%$5.02
35

Other major holders of ALDX: BNP PARIBAS FINANCIAL MARKETS, Verition Fund Management LLC, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used